Publications 2018

Clementy, N., Garcia, B., André, C., Bisson, A., Benhenda, N., Pierre, B., Bernard, A., Fauchier, L., Piver, E., Babuty, D., 2018b. Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure. PLoS ONE 13, e0201517. https://doi.org/10.1371/journal.pone.0201517

Clementy, N., Piver, E., Bisson, A., Andre, C., Bernard, A., Pierre, B., Fauchier, L., Babuty, D., 2018c. Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications. Int J Mol Sci 19. https://doi.org/10.3390/ijms19040976

Dutta, S., Lopez Charcas, O., Tanner, S., Gradek, F., Driffort, V., Roger, S., Selander, K., Velu, S.E., Brouillette, W., 2018. Discovery and evaluation of nNav1.5 sodium channel blockers with potent cell invasion inhibitory activity in breast cancer cells. Bioorg. Med. Chem. 26, 2428–2436. https://doi.org/10.1016/j.bmc.2018.04.003

Gatault, P., Al-Hajj, S., Noble, J., Chevallier, E., Piollet, M., Forconi, C., Gaudy-Graffin, C., Thibault, G., Miquelestorena-Standley, E., Halimi, J.-M., Büchler, M., Lemoine, R., Baron, C., 2018. CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells. Am. J. Transplant. 18, 1904–1913. https://doi.org/10.1111/ajt.14672

Greco, M.R., Bon, E., Rubino, R., Guerra, L., Bernabe-Garcia, M., Cannone, S., Cayuela, M.-L., Ciaccia, L., Marionneau-Lambot, S., Oullier, T., Fromont, G., Guibon, R., Roger, S., Reshkin, S.J., Cardone, R.A., 2019. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism. Biochim Biophys Acta Mol Basis Dis 1865, 26–37. https://doi.org/10.1016/j.bbadis.2018.10.017

Lefort, C., Benoist, L., Chadet, S., Piollet, M., Heraud, A., Babuty, D., Baron, C., Ivanes, F., Angoulvant, D., 2018. Stimulation of P2Y11 receptor modulates cardiac fibroblasts secretome toward immunomodulatory and protective roles after Hypoxia/Reoxygenation injury. J. Mol. Cell. Cardiol. 121, 212–222. https://doi.org/10.1016/j.yjmcc.2018.07.245

Moussata, D., Allez, M., Cazals-Hatem, D., Treton, X., Laharie, D., Reimund, J.-M., Bertheau, P., Bourreille, A., Lavergne-Slove, A., Brixi, H., Branche, J., Gornet, J.-M., Stefanescu, C., Moreau, J., Marteau, P., Pelletier, A.-L., Carbonnel, F., Seksik, P., Simon, M., Fléjou, J.-F., Colombel, J.-F., Charlois, A.-L., Roblin, X., Nancey, S., Bouhnik, Y., Berger, F., Flourié, B., the GETAID, 2018. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut 67, 616–624. https://doi.org/10.1136/gutjnl-2016-311892

Ternant, D., Passot, C., Aubourg, A., Goupille, P., Desvignes, C., Picon, L., Lecomte, T., Mulleman, D., Paintaud, G., 2018. Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration. Clin Pharmacokinet 57, 1173–1184. https://doi.org/10.1007/s40262-017-0621-6

Wei, L., Syed Mortadza, S.A., Yan, J., Zhang, L., Wang, L., Yin, Y., Li, C., Chalon, S., Emond, P., Belzung, C., Li, D., Lu, C., Roger, S., Jiang, L.-H., 2018. ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. Neurosci Biobehav Rev 87, 192–205. https://doi.org/10.1016/j.neubiorev.2018.02.005